getting pregnant on glp-1 The hidden impact of GLP‐1 receptor agonists endometrial receptivity and implantation - Sola‐Leyva - 2025 - Acta Obstetricia et Gynecologica Scandinavica New data on GLP-1s &

Newer studies however, do not support the contention of a generalized defect in nutrient-related GLP-1 secretory responses in people with T2D, but rather suggest that the inter-individual differences in GLP-1 secretion, age of patients, duration of diabetes, concomitant drug therapy, and other variables play a role, and preclude definitive conclusions that diabetes is invariably associated with reduced GLP-1 secretion [22]

What Our Users Say This app is easy to use and a wonderful way to stay on target with your goals

To date, these GLP-1 drugs have been approved to treat three adult populations: individuals with type 2 diabetes, individuals with a body mass index (BMI) of 30 or greater (obesity), and individuals with a BMI between 27 and 30 (overweight) with at least one weight-related health condition, such as cardiovascular disease, high blood pressure, high cholesterol, prior stroke, prior heart attack, and chest pain (angina)

Ask what happens between your visits

Most GLP-1 probiotics fall into a few broad categories

Weve then assumed that 30% of these people will ultimately end up on GLP-1 receptor agonist drugs, or 3.3m people, which is around 5% of the overall population